Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Performance
Open
667.00Prev. Close
677.95Volume
3,600Total traded value
0.25 CrUpper Circuit
821.25Lower Circuit
547.55Fundamentals
| Market Cap | ₹807Cr |
| ROE | 11.36% |
| P/E Ratio(TTM) | 20.99 |
| EPS(TTM) | 32.60 |
| P/B Ratio | 3.15 |
| Dividend Yield | 0.11% |
| Industry P/E | 34.67 |
| Book Value | 217.13 |
| Debt to Equity | 0.09 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Remus Pharmaceuticals
Remus Pharmaceuticals is an Indian company engaged in the international marketing and distribution of pharmaceutical products for the global healthcare sector. The company operates with the core belief of creating a positive difference in people's lives through its various healthcare solutions. Demonstrating significant financial performance, its Profit After Tax surged by 153.29% in the 2024 fiscal year compared to the previous year.;
| Parent Organisation | Remus Pharmaceuticals |
| Managing Director | Mr. Arpit Shah |
| NSE Symbol | REMUS |
Shareholding Pattern
Mar '24
Jun '24
Sep '24
Mar '25
Jul '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 71.87 | ||
| Anthem Biosciences | NA (0.00%) | 99.52 | ||
| Onesource Specialty Pharma | NA (0.00%) | 314.17 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.57 |